The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
News|Slideshows|September 2, 2020
Considering Aspirin: 8 Questions on Primary CVD Prevention
Author(s)Aparna Sajja, MD , Seth Martin, MD, MHS
The role of aspirin in primary prevention of CV disease changed for good with results from 3 pivotal trials. Do you recall results and recommendations? Find out.
Advertisement
Remember ARRIVE, ASCEND, and ASPREE–the 3 pivotal randomized controlled trials conducted in nearly 50,000 patients in a variety of possible scenarios that changed the place of aspirin in primary cardiovascular disease prevention for good?
Try this 8-question quiz as a refresher on the study outcomes, the recommendations and patient selection for aspirin use in primary prevention of CVD.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
Advertisement
Advertisement
Trending on Patient Care Online
1
Capsule-Sponge Testing Could Help Close the Barrett’s Screening Gap: An Expert Q&A
2
Elinzanetant Linked to Broad Improvements in Sleep Disturbance in Women With Moderate-to-Severe Vasomotor Symptoms
3
Insulin Resistance May Partly Explain Higher Cardiovascular Risk After Premature Menopause
4
AI-Enhanced Virtual Reality Program Delivering CBT Shows Early Feasibility for Menopause Symptoms: TMS 2026
5